The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Metrotop 8mg/ml Topical Gel

Ayrton Saunders (Ireland) LimitedPA22906/004/001

Main Information

Trade NameMetrotop 8mg/ml Topical Gel
Active SubstancesMetronidazole
Dosage FormGel
Licence HolderAyrton Saunders (Ireland) Limited
Licence NumberPA22906/004/001

Group Information

ATC CodeD06BX Other chemotherapeutics
D06BX01 metronidazole


License statusAuthorised
Licence Issued19/04/1991
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back